IHS Chemical Week

People & Business :: Companies

Syngenta Invests in U.S. Biotech Firm

2:53 AM MDT | October 27, 2009 | Deepti Ramesh

Syngenta says its newly-established Syngenta Ventures corporate venture capital subsidiary, has made an equity investment in Metabolon (Durham, NC), a privately-held biotechnology company focused on the use of metabolomics in research and diagnostics. This is the first direct investment by Syngenta Ventures. Financial details of the equity investment in Metabolon were not disclosed. Metabolomics provides mechanistic insight and biochemical markers for complex biological processes, Syngenta says. This technology aims to accelerate the development of plants with...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa